PRLD 8-K 2026-01-09

Prelude Therapeutics Inc (PRLD) 8-K dated 2026-01-09 — accession 0001193125-26-008280. This URL is the filing, not the PRLD hub.

Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.

Prelude Therapeutics Inc filed a 8-K on 2026-01-09. Accession 0001193125-26-008280.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PRLD revenue for 2026-06-30 was $10.3M. Net income was -$24.3M. PRLD currently screens at market cap $346.5M.

Not investment advice. The PRLD SEC hub lists recent forms. The stock page is the research view.